14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $16.60 $18.63 Tuesday, 23rd Apr 2024 ACAD stock ended at $16.74. This is 1.47% less than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 3.76% from a day low at $16.61 to a day high of $17.23.
90 days $16.60 $29.29
52 weeks $16.60 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Apr 23, 2024 $17.09 $17.23 $16.61 $16.74 1 404 429
Apr 22, 2024 $17.02 $17.34 $16.94 $16.99 1 052 256
Apr 19, 2024 $16.98 $17.30 $16.62 $16.82 2 781 966
Apr 18, 2024 $17.26 $17.35 $17.01 $17.07 988 271
Apr 17, 2024 $17.25 $17.25 $16.97 $17.19 955 114
Apr 16, 2024 $16.75 $17.20 $16.60 $17.08 950 683
Apr 15, 2024 $17.13 $17.28 $16.77 $16.89 1 064 618
Apr 12, 2024 $17.40 $17.62 $16.85 $17.14 1 256 467
Apr 11, 2024 $17.90 $17.90 $17.34 $17.41 1 412 418
Apr 10, 2024 $17.72 $17.77 $17.55 $17.73 1 047 659
Apr 09, 2024 $17.94 $18.25 $17.84 $18.15 1 300 178
Apr 08, 2024 $17.87 $18.08 $17.63 $17.80 1 702 961
Apr 05, 2024 $17.91 $18.25 $17.61 $18.01 1 150 767
Apr 04, 2024 $18.52 $18.63 $18.03 $18.05 1 115 677
Apr 03, 2024 $18.00 $18.47 $18.00 $18.42 1 322 249
Apr 02, 2024 $18.04 $18.25 $17.86 $18.11 1 227 152
Apr 01, 2024 $18.59 $18.59 $17.91 $18.26 1 131 227
Mar 28, 2024 $18.20 $18.50 $18.05 $18.49 1 481 512
Mar 27, 2024 $17.90 $18.20 $17.73 $18.20 1 622 201
Mar 26, 2024 $17.95 $18.02 $17.68 $17.79 1 367 254
Mar 25, 2024 $18.00 $18.18 $17.56 $17.84 1 781 975
Mar 22, 2024 $18.34 $18.39 $17.91 $17.95 1 480 398
Mar 21, 2024 $18.67 $19.00 $18.31 $18.41 1 929 481
Mar 20, 2024 $18.60 $18.78 $18.30 $18.66 1 403 534
Mar 19, 2024 $18.63 $18.91 $18.47 $18.70 1 845 378
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT